These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 11239205)

  • 1. Atrial fibrillation and stroke : concepts and controversies.
    Hart RG; Halperin JL
    Stroke; 2001 Mar; 32(3):803-8. PubMed ID: 11239205
    [No Abstract]   [Full Text] [Related]  

  • 2. Left atrial appendage occlusion eliminates the need for warfarin.
    Holmes DR; Schwartz RS
    Circulation; 2009 Nov; 120(19):1919-26; discussion 1926. PubMed ID: 19901202
    [No Abstract]   [Full Text] [Related]  

  • 3. Do A-fib patients continue to benefit from vitamin K antagonists with advancing age?
    Guthmann R; Bahrami A; Martin R; Nashelsky J
    J Fam Pract; 2019; 68(6):E12-E14. PubMed ID: 31381630
    [No Abstract]   [Full Text] [Related]  

  • 4. [Anticoagulation in atrial fibrillation. Stroke can be prevented this way].
    Thorsten L
    MMW Fortschr Med; 2009 Sep; 151(36):53. PubMed ID: 19813543
    [No Abstract]   [Full Text] [Related]  

  • 5. Prevention of stroke in patients with atrial fibrillation.
    Med Lett Drugs Ther; 2009 Jun; 51(1313):41. PubMed ID: 19478692
    [No Abstract]   [Full Text] [Related]  

  • 6. Left atrial appendectomy and maze.
    Bonanomi G; Zenati MA; Schwartzman D
    J Am Coll Cardiol; 2003 Jan; 41(1):170; author reply 170-1. PubMed ID: 12570963
    [No Abstract]   [Full Text] [Related]  

  • 7. Antithrombotic treatment in atrial fibrillation.
    Lip GY; Boos CJ
    Postgrad Med J; 2008 May; 84(991):252-8. PubMed ID: 18508982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contra: "Anti-platelet therapy is an alternative to oral anticoagulation for atrial fibrillation".
    Apostolakis S; Shantsila E; Lip GY; Lane DA
    Thromb Haemost; 2009 Nov; 102(5):914-5. PubMed ID: 19888529
    [No Abstract]   [Full Text] [Related]  

  • 9. Noncentral Nervous System Systemic Embolism in Patients With Atrial Fibrillation: Results From ROCKET AF (Rivaroxaban Once Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation).
    Orgel R; Wojdyla D; Huberman D; Halperin JL; Breithardt G; Singer DE; Fox KAA; Hankey GJ; Mahaffey KW; Jones WS; Patel MR
    Circ Cardiovasc Qual Outcomes; 2017 May; 10(5):. PubMed ID: 28495674
    [No Abstract]   [Full Text] [Related]  

  • 10. Randomized controlled trials of new oral anticoagulants for stroke prevention in atrial fibrillation.
    Liew A; Eikelboom JW; O'Donnell M
    Curr Opin Cardiol; 2012 Jul; 27(4):331-9. PubMed ID: 22573171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ximelagatran or warfarin in atrial fibrillation?
    Stöllberger C; Finsterer J
    Lancet; 2004 Feb; 363(9410):734-5; author reply 736. PubMed ID: 15001336
    [No Abstract]   [Full Text] [Related]  

  • 12. Stroke prevention in atrial fibrillation.
    Freedman B; Potpara TS; Lip GY
    Lancet; 2016 Aug; 388(10046):806-17. PubMed ID: 27560276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: prevention of stroke and systemic thromboembolism in atrial fibrillation and flutter.
    Cairns JA; Connolly S; McMurtry S; Stephenson M; Talajic M;
    Can J Cardiol; 2011; 27(1):74-90. PubMed ID: 21329865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preventing stroke in patients with atrial fibrillation: current treatments and new concepts.
    Connolly SJ
    Am Heart J; 2003 Mar; 145(3):418-23. PubMed ID: 12660663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of concomitant aspirin in patients with atrial fibrillation: Findings from the ROCKET AF trial.
    Shah R; Hellkamp A; Lokhnygina Y; Becker RC; Berkowitz SD; Breithardt G; Hacke W; Halperin JL; Hankey GJ; Fox KA; Nessel CC; Mahaffey KW; Piccini JP; Singer DE; Patel MR;
    Am Heart J; 2016 Sep; 179():77-86. PubMed ID: 27595682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Newer anticoagulants as an alternate to warfarin in atrial fibrillation: a changing paradigm.
    Chaudhari D; Bhuriya R; Arora R
    Am J Ther; 2011 Jan; 18(1):e1-e11. PubMed ID: 20460986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Left atrial appendage occlusion does not eliminate the need for warfarin.
    Whitlock RP; Healey JS; Connolly SJ
    Circulation; 2009 Nov; 120(19):1927-32; discussion 1932. PubMed ID: 19901203
    [No Abstract]   [Full Text] [Related]  

  • 18. Cost-effectiveness of dabigatran versus vitamin K antagonists for the prevention of stroke in patients with atrial fibrillation: a French payer perspective.
    Chevalier J; Delaitre O; Hammès F; de Pouvourville G
    Arch Cardiovasc Dis; 2014; 107(6-7):381-90. PubMed ID: 24973113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lessons from the Stroke Prevention in Atrial Fibrillation trials.
    Hart RG; Halperin JL; Pearce LA; Anderson DC; Kronmal RA; McBride R; Nasco E; Sherman DG; Talbert RL; Marler JR;
    Ann Intern Med; 2003 May; 138(10):831-8. PubMed ID: 12755555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice?
    Go AS; Hylek EM; Chang Y; Phillips KA; Henault LE; Capra AM; Jensvold NG; Selby JV; Singer DE
    JAMA; 2003 Nov; 290(20):2685-92. PubMed ID: 14645310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.